Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.

Veitonmäki T, Tammela TL, Auvinen A, Murtola TJ.

Eur J Cancer. 2013 Mar;49(4):938-45. doi: 10.1016/j.ejca.2012.09.030. Epub 2012 Oct 15.

PMID:
23079475
2.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

3.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

4.

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.

Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sørensen HT.

BMJ. 2011 Jul 4;343:d3450. doi: 10.1136/bmj.d3450.

5.

Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.

García Rodríguez LA, González-Pérez A.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):649-53.

6.

Aspirin and the risk of prostate cancer.

Bosetti C, Talamini R, Negri E, Franceschi S, Montella M, La Vecchia C.

Eur J Cancer Prev. 2006 Feb;15(1):43-5.

PMID:
16374228
7.

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2226-32.

8.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

9.

Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.

Veitonmäki T, Murtola TJ, Määttänen L, Taari K, Stenman UH, Tammela TL, Auvinen A.

Prostate. 2015 Sep;75(13):1394-402. doi: 10.1002/pros.23020. Epub 2015 Jun 12.

PMID:
26073992
10.

Underutilization of preventive strategies in patients receiving NSAIDs.

Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.

Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31.

11.

A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark.

Chang ET, Frøslev T, Sørensen HT, Pedersen L.

Br J Cancer. 2011 Nov 22;105(11):1776-82. doi: 10.1038/bjc.2011.443. Epub 2011 Oct 25.

12.

Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.

Wilson JC, O'Rorke MA, Cooper JA, Murray LJ, Hughes CM, Gormley GJ, Anderson LA.

Cancer Epidemiol. 2013 Dec;37(6):897-904. doi: 10.1016/j.canep.2013.08.010. Epub 2013 Sep 14.

PMID:
24042024
13.

Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.

Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sørensen HT.

Cancer. 2012 Oct 1;118(19):4768-76. doi: 10.1002/cncr.27406. Epub 2012 May 29.

14.

Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.

Mahmud SM, Tanguay S, Bégin LR, Franco EL, Aprikian AG.

Eur J Cancer Prev. 2006 Apr;15(2):158-64.

PMID:
16523013
15.

"Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs.

Bennett K, Teeling M, Feely J.

Eur J Clin Pharmacol. 2003 Nov;59(8-9):645-9. Epub 2003 Aug 27.

PMID:
12942226
16.

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.

Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.

BMC Cancer. 2005 Dec 12;5:159.

17.

The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control study.

Kemppainen KJ, Tammela TL, Auvinen A, Murtola TJ.

Cancer Causes Control. 2011 Oct;22(10):1445-52. doi: 10.1007/s10552-011-9819-3. Epub 2011 Jul 19.

PMID:
21769492
18.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

19.
20.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

Items per page

Supplemental Content

Write to the Help Desk